OliX Pharmaceuticals Subsidiary mCureX Announces mRNA Technology Collaboration with ToolGen for Rare Eye Disease
SUWON, South Korea--(BUSINESS WIRE)--#AgeRelatedMacularDegeneration--OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, today announced that…